Unlock stock picks and a broker-level newsfeed that powers Wall Street.

How Did China Resources Medical Holdings Company Limited's (HKG:1515) 7.7% ROE Fare Against The Industry?

In This Article:

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. To keep the lesson grounded in practicality, we'll use ROE to better understand China Resources Medical Holdings Company Limited (HKG:1515).

Our data shows China Resources Medical Holdings has a return on equity of 7.7% for the last year. That means that for every HK$1 worth of shareholders' equity, it generated HK$0.077 in profit.

Check out our latest analysis for China Resources Medical Holdings

How Do I Calculate ROE?

The formula for ROE is:

Return on Equity = Net Profit ÷ Shareholders' Equity

Or for China Resources Medical Holdings:

7.7% = CN¥431m ÷ CN¥5.7b (Based on the trailing twelve months to December 2018.)

It's easy to understand the 'net profit' part of that equation, but 'shareholders' equity' requires further explanation. It is all earnings retained by the company, plus any capital paid in by shareholders. Shareholders' equity can be calculated by subtracting the total liabilities of the company from the total assets of the company.

What Does Return On Equity Signify?

ROE measures a company's profitability against the profit it retains, and any outside investments. The 'return' is the yearly profit. The higher the ROE, the more profit the company is making. So, as a general rule, a high ROE is a good thing. Clearly, then, one can use ROE to compare different companies.

Does China Resources Medical Holdings Have A Good ROE?

By comparing a company's ROE with its industry average, we can get a quick measure of how good it is. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. You can see in the graphic below that China Resources Medical Holdings has an ROE that is fairly close to the average for the Healthcare industry (8.1%).

SEHK:1515 Past Revenue and Net Income, August 9th 2019
SEHK:1515 Past Revenue and Net Income, August 9th 2019

That isn't amazing, but it is respectable. ROE doesn't tell us if the share price is low, but it can inform us to the nature of the business. For those looking for a bargain, other factors may be more important. I will like China Resources Medical Holdings better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

How Does Debt Impact ROE?

Most companies need money -- from somewhere -- to grow their profits. That cash can come from issuing shares, retained earnings, or debt. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the use of debt will improve the returns, but will not change the equity. That will make the ROE look better than if no debt was used.